Literature DB >> 20444043

Penetration of enrofloxacin into the nasal secretions and relationship between nasal secretions and plasma enrofloxacin concentrations after intramuscular administration in healthy pigs.

M Bimazubute1, C Cambier, K Baert, S Vanbelle, P Chiap, A Albert, J P Delporte, P Gustin.   

Abstract

The pharmacokinetic behaviour of enrofloxacin (ENRO) in plasma and nasal secretions of healthy pigs was investigated, after a single-dose intramuscular administration of 2.5 mg/kg body weight of the drug. Blood samples and nasal secretions were collected at predetermined times after drug administration. Concentrations of ENRO and its active metabolite ciprofloxacin (CIPRO) were determined in plasma and nasal secretions by high-performance liquid chromatography (HPLC). CIPRO was not detected probably because we investigated young weaned pigs. The data collected in 12 pigs for ENRO were subjected to noncompartmental analysis. In plasma, the maximum concentration of drug (C(max)), the time at which this maximum concentration of drug (T(max)) was reached, the elimination half-life (t(1/2)(beta)) and the area under the concentration vs. time curve (AUC) were, respectively, 694.7 ng/mL, 1.0 h, 9.3 h and 8903.2 ngxh/mL. In nasal secretions, C(max), T(max), t(1/2)(beta) and AUC were, respectively, 871.4 ng/mL, 2.0 h, 12.5 h and 11 198.5 ngxh/mL. In a second experiment conducted in 10 piglets, the relationship between concentrations of ENRO measured in the plasma and the nasal secretions has been determined following single-dose intramuscular administration of 2.5, 10 or 20 mg/kg body weight of the drug. It has been demonstrated that, among several variables, i.e., (1) the dose administered, (2) the time between intramuscular injection and blood sampling, (3) the age, (4) the sex, (5) the animal body weight and (6) the plasma concentration of the drug, only the latter influenced significantly the ENRO concentration in nasal secretions. Practically, using a generalized linear mixed model, ENRO concentrations in the nasal secretions (microg/mL) can be predicted taking into account the ENRO concentrations in plasma (microg/mL), according to the following equation:

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20444043     DOI: 10.1111/j.1365-2885.2009.01123.x

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN: 0140-7783            Impact factor:   1.786


  7 in total

1.  Effect of enrofloxacin in the carrier stage of Haemophilus parasuis in naturally colonized pigs.

Authors:  Nubia Macedo; Albert Rovira; Simone Oliveira; Andrew Holtcamp; Montserrat Torremorell
Journal:  Can J Vet Res       Date:  2014-01       Impact factor: 1.310

2.  Susceptibility breakpoint for enrofloxacin against swine Salmonella spp.

Authors:  Haihong Hao; Huafang Pan; Ijaz Ahmad; Guyue Cheng; Yulian Wang; Menghong Dai; Yanfei Tao; Dongmei Chen; Dapeng Peng; Zhenli Liu; Lingli Huang; Zonghui Yuan
Journal:  J Clin Microbiol       Date:  2013-06-19       Impact factor: 5.948

3.  Preparation and evaluation of enrofloxacin microspheres and tissue distribution in rats.

Authors:  Fan Yang; Jijun Kang; Fang Yang; Zhensheng Zhao; Tao Kong; Zhenling Zeng
Journal:  J Vet Sci       Date:  2015-01-30       Impact factor: 1.672

4.  Pharmacokinetic and Pharmacodynamic Integration and Modeling of Enrofloxacin in Swine for Escherichia coli.

Authors:  Jianyi Wang; Haihong Hao; Lingli Huang; Zhenli Liu; Dongmei Chen; Zonghui Yuan
Journal:  Front Microbiol       Date:  2016-02-02       Impact factor: 5.640

5.  Clinical Efficacy and Residue Depletion of 10% Enrofloxacin Enteric-Coated Granules in Pigs.

Authors:  Zhixin Lei; Qianying Liu; Bing Yang; Jincheng Xiong; Kun Li; Saeed Ahmed; Liping Hong; Pin Chen; Qigai He; Jiyue Cao
Journal:  Front Pharmacol       Date:  2017-05-23       Impact factor: 5.810

6.  Susceptibility breakpoint for Danofloxacin against swine Escherichia coli.

Authors:  Yuqi Yang; Yixin Zhang; Jiarui Li; Ping Cheng; Tianshi Xiao; Ishfaq Muhammad; Hongxiao Yu; Ruimeng Liu; Xiuying Zhang
Journal:  BMC Vet Res       Date:  2019-02-04       Impact factor: 2.741

Review 7.  Pharmacokinetics/Pharmacodynamics models of veterinary antimicrobial agents.

Authors:  Wanhe Luo; Dongmei Chen; Mengru Wu; Zhenxia Li; Yanfei Tao; Qianying Liu; Yuanhu Pan; Wei Qu; Zonghui Yuan; Shuyu Xie
Journal:  J Vet Sci       Date:  2019-09       Impact factor: 1.672

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.